ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

Budget Cut Asked By Ford Would Hold Grant Funding To 20%

January 10, 1975

Compendia Publishers Must Tell CMS How They Manage Conflicts Of Interest

November 13, 2009

Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;

January 10, 2003

Stimulus Bill Gives NIH A $10 Billion Boost Over Two Years, Puts Pressure On Institutes to Make Rapid Funding Decisions

February 13, 2009

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013